Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genosomes are promising for safe and effective gene delivery in therapy.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

Advancements in biomaterials and nanotechnology are improving medical applications like hair growth, bone regeneration, and cancer treatment.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Certain genes may influence hair loss differently in men and women.

The representation of skin conditions in medical reviews partly matches their real-world impact.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Ongoing monitoring and treatment are crucial to manage sarcoptic mange in reintroduced red foxes.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Probiotics may help manage celiac disease by improving gut health and reducing symptoms.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Hemp shows promise for skincare and hair care due to its therapeutic properties, but standardization and clinical evidence are needed.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.